HydroCision
hydrocision.com
Actively hiring
Health Care
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$5.5M
2 rounds on record
Latest round
$2.5M
Venture round · Nov 2024 · 22 mo ago
Team
11-50
employees, estimated range
Revenue
$5M
2024 · SEC Form D 0001031309-25-000003
Backers
1
Omega Funds
The money's age
Due for its next round
22 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 15, 2024
Raised a round Venture round $2.5M · SEC Form D
Mar 5, 2019
New executive HydroCision Appoints Medical Device Executive with Global Commercial and Market Development Experience as New CEO · markets.businessinsider.com
Mar 9, 2017
Raised a round Venture round $3M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2024 | $2.5M | — | SEC Form D |
| Venture round | Mar 2017 | $3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | HYDROCISION INC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Patricia VanblarcomExecutive OfficerSEC Form D
Paul KowalskiExecutive OfficerSEC Form D
Richard Lytle IiiExecutive Officer, DirectorSEC Form D
Thomas AbertExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Omega Funds Similar startupsby what they do, their industry and backers
Simplify 3D surgical case planning with Enhatch – your all-in-one virtual planning solution for 3D printed implants and guides for…
Digital patient engagement and remote monitoring platform to improve patient experience and clinical outcomes, collect PROs, automate…
Network Bio builds AI on the world's largest patient tissue training dataset, linked to blood samples and clinical outcomes from top US…
A comprehensive platform for care that happens between visits, Canopy enhances patient care, improves clinical workflows, and generates new…
关于我们 为改善亿万病患的生活品质而努力 集团介绍 爱康医疗成立于2003年，是一家集骨科前沿技术研究、创新产品开发、规模化制造和专业化营销的国际化骨科产业集团，2017年在香港主板上市（01789.HK）。…
Lift to Zenith with Novel Myeloid Engager Therapeutics. To maximize the drugability potential, we target approaches to improve clinical…
News
Not All Heel Pain is the Same
By Michael Dakkak, DO Dr. Dakkak is a fellowship-trained sports medicine physician practicing at Cleveland Clinic Weston Hospital in Florida. He specializes in non-surgical treatment options for treating orthopedic injuries or chronic pain. Plantar fascio
Read more
Report
TenJet Patient Story: "TenJet gave me renewed optimism"
A Marathon Runner's Hamstring Pain Megan M., a runner from Cleveland, OH, struggled with chronic tendon pain in her hamstrings for over fifteen years. Read this Q&A with Megan to learn about her experience with TenJet. HydroCision: What led you to seek tr
Read more
Report
Understanding Epicondilytis-Elbow Tendinitis or Tendinosis?
By Michael Dakkak, DO Dr. Dakkak is a fellowship-trained sports medicine physician practicing at Cleveland Clinic Weston Hospital in Florida. He specializes in non-surgical treatment options for treating orthopedic injuries or chronic pain. Epicondylitis
Read more
Report
TenJet Patient Story: "Thankful every day"
Tendinopathy leading to knee pain C.P., of Akron, OH, is a 60-year-old woman who likes to be active. About 5 years ago, general overuse and age began causing pain in her gluteus muscles. After undergoing a range of tests, she was diagnosed with tendinopat
Read more
Report
TenJet Patient Story: "It felt like a miracle."
An ultramarathon runner's hamstring pain Josh Irvan of Downington, Pennsylvania, is a very active person. On top of teaching art at a military school and spending time with his wife and two daughters, he is an avid runner. Irvan is not your average jogger
Read more
Report
Pro access
Upgrade to see all 19 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Patricia Vanblarcom
Executive Officer
Paul Kowalski
Executive Officer
Richard Lytle Iii
Executive Officer, Director
Thomas Abert
Executive Officer
Doug Wall
Director
Terry Wall
Director
Yu Xiaotong
Director
Howard Donnelly
Director
Marc Goldberg
Director
Long Zhan
Director
Bryan Grulke
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Financials
Est. Annual Revenue
$3M
2024
Total raised
$5.5M
Latest round
Venture - Series Unknown
Funding rounds
2
Revenue
Estimate
Low-high range
Modelled from public signals, not audited accounts - read it as an order of magnitude.
| Year | Estimate | Low | High |
|---|---|---|---|
| 2016 | $3M | $1M | $5M |
| 2024 | $3M | $1M | $5M |